Autophagy in Cancer Therapy-Molecular Mechanisms and Current Clinical Advances.

While the primary endpoint, a reduction greater than or equal to a 0.5 log decrease in disease burden 12 months in, was not reached, the secondary endpoint for this analysis at 24 months was higher in the HCQ-containing group with a strong trend although not statistically significant.

also in 5,725 other papers